- Report
- January 2024
- 289 Pages
Global
From €7206EUR$7,500USD£6,186GBP
Supartz is a brand of hyaluronic acid (HA) injection used to treat musculoskeletal disorders. It is a non-surgical treatment option for osteoarthritis of the knee, providing relief from pain and inflammation. The HA is injected directly into the knee joint, where it acts as a lubricant and shock absorber. It is also used to treat other musculoskeletal disorders, such as tendinitis, bursitis, and plantar fasciitis.
The Supartz market is a growing segment of the musculoskeletal disorders drugs market. It is a relatively new treatment option, and is gaining popularity due to its effectiveness and non-invasive nature. It is also cost-effective compared to other treatments, such as surgery.
Some companies in the Supartz market include Zimmer Biomet, Sanofi, and Fidia Farmaceutici. Show Less Read more